Christine Brezden‐Masley
Mount Sinai Hospital(CA)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Chemotherapy-induced cardiotoxicity and mitigation, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study(2020)865 cited
- → Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society(2020)735 cited
- → Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes(2016)369 cited
- → Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy(2016)228 cited
- → Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines(2016)217 cited
- → Outlooks on Epstein-Barr virus associated gastric cancer(2018)214 cited
- → Use of an Abridged Scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a Nutritional Screening Tool for Cancer Patients in an Outpatient Setting(2013)196 cited
- → BRCA1 is an essential regulator of heart function and survival following myocardial infarction(2011)147 cited
- → Overcoming Endocrine Resistance in Hormone Receptor–Positive Breast Cancer(2018)136 cited
- → Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines(2023)95 cited